<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129553">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02061176</url>
  </required_header>
  <id_info>
    <org_study_id>Holbaek Haemorrhoid Study</org_study_id>
    <nct_id>NCT02061176</nct_id>
  </id_info>
  <brief_title>THD Versus Open Haemorrhoidectomy</brief_title>
  <official_title>Transanal Haemorrhoidal Dearterialization (THD) Versus Open Haemorrhoidectomy for the Treatment of Haemorrhoids. An Open Prospective Randomized Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Holbaek Sygehus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Holbaek Sygehus</source>
  <oversight_info>
    <authority>Denmark: The Regional Committee on Biomedical Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised study comparing Transanal Haemorrhoidal Dearterialization (THD) and Open
      Haemorrhoidectomy (OH) for the treatment of prolapsing haemorrhoids. The primary aim of the
      study is to evaluate the long-term effect on haemorrhoidal symptoms one year
      postoperatively.

      Secondary endpoints are postoperative pain, complications, effect on anal continence,
      recovery and return to normal activity, quality of life and health cost analysis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Haemorrhoidal Symptoms</measure>
    <time_frame>1-year postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Five questions regarding haemorrhoidal symptoms (pain, bleeding, itching, soiling and prolapse) are used to grade the symptom load. Each symptom is graded from 0-4, giving a total score from 0-20.
The symptom score is registered preoperatively, 3 and 12 months postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>14 days postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Postoperative pain is registered using visual analog scale (VAS), by the hospital staff in the immediate postoperative course during hospital stay and by the patient the first 14 days postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1-year postoperatively</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Early and late complications are registered at 3 and 12 months follow up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anal continence</measure>
    <time_frame>1-year postoperatively</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Effect on anal continence is evaluated by Wexner Anal Incontinence Score and Revised Faecal Incotinence Score (RFIS) preoperatively, 3- and 12 months postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>1-year postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>QoL is evaluated using Short Form(SF)-36 and EQ-5D preoperatively and 1-year postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health cost analysis</measure>
    <time_frame>1-year postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Health cost analysis will be based on an estimate of the cost of the operations, recovery of the patients and effect (need for further procedures or medical care).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Hemorrhoids</condition>
  <arm_group>
    <arm_group_label>Transanal Haemorrhoidal Dearterialization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomised to Transanal Haemorrhoidal Dearterialization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open Haemorrhoidectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomised to Open Haemorrhoidectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transanal Haemorrhoidal Dearterialization</intervention_name>
    <arm_group_label>Transanal Haemorrhoidal Dearterialization</arm_group_label>
    <other_name>Hemorrhoidal Artery Ligation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Haemorrhoidectomy</intervention_name>
    <arm_group_label>Open Haemorrhoidectomy</arm_group_label>
    <other_name>Milligan Morgan</other_name>
    <other_name>Haemorrhoidectomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient has Grade III-IV haemorrhoids or Grade II haemorrhoids with bleeding
             resistant to rubber band ligation or sclerotherapy

          -  The patient has a Haemorrhoidal Symptom Score of 4 or more

          -  The patient has an American Society of Anaesthesiologists (ASA) score I-II

          -  The patient's age is 18-85 years at inclusion

          -  The patient has had a colonoscopy, sigmoidoscopy or rigid rectoscopy within 3 months
             before inclusion

        Exclusion Criteria:

          -  The patient has had previous operation for haemorrhoids within the last 2 years

          -  The patient has had previous operation for anal incontinence

          -  The patient has an active anal fistula

          -  The patient has an active anal fissure

          -  The patient has anal incontinence for solid stools
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gunnar Olaison, MD, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Departement of Surgery, Holbaek County Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Departement of Surgery, Holbaek County Hospital.</name>
      <address>
        <city>Holbaek</city>
        <zip>4300</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunnar Olaison, MD, Ph.D</last_name>
      <email>poo@regionsjaelland.dk</email>
    </contact>
    <contact_backup>
      <last_name>Havard Roervik, MD</last_name>
      <email>hdro@regionsjaelland.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Gunnar Olaison, MD, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 11, 2014</lastchanged_date>
  <firstreceived_date>February 11, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Holbaek Sygehus</investigator_affiliation>
    <investigator_full_name>Per Olov Gunnar Olaison</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Hemorrhoids</keyword>
  <keyword>Haemorrhoids</keyword>
  <keyword>Transanal Haemorrhoidal Dearterialization</keyword>
  <keyword>Transanal Hemorrhoidal Dearterialisation</keyword>
  <keyword>Open Haemorrhoidectomy</keyword>
  <keyword>Open Hemorrhoidectomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
